Alkem Laboratories Limited shared the earnings call transcript for Q1 FY2025, highlighting improved profitability, resolved FDA compliance issues, and plans for growth in domestic and emerging markets.
AI Assistant
Alkem Laboratories Ltd
2024
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.